HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.

Abstract
We investigated the relationship between clinical, laboratory and genetic markers and outcome measures in 159 patients with recent onset of inflammatory arthritis (IA). The majority of patients were managed in community-based rheumatology practice. Median duration of arthritis at baseline was 3 months with median follow-up of 4.0 years (range 0-10). Markers of disease activity and 1987 ACR criteria for rheumatoid arthritis (RA) were estimated every 6 months for the first 2 years and annually thereafter. Presence of shared epitopes (SE) was established by PCR-based method. Main outcome variables were attainment of remission and presence of erosions on X-rays of hands and feet at 3 years. Remission was seen in 34.3% of patients and was independently related to age 60 and older (odds ratio (OR) 3.2; 95% confidence interval (CI), 1.2-8.7) and inversely to the presence of rheumatoid factor (RF) (OR 8.3; 95% CI, 3.2-21.3 for persistent arthritis). Patients with two SE were likely to have persistent arthritis (P=0.006), but this was not significant when corrected for RF. Independent predictors for erosions at 3 years were RF (OR 7.5; 95% CI, 1.9-29.5) and area under the curve for number of swollen joints (OR 1.08; 95% CI, 1.02-1.16). SE status was not predictive of erosions at 3 years (OR 1.6; 95% CI, 0.7-3.7). In univariate analysis, patients possessing DERAA motif on DRB1 were less likely to have erosive disease than without this motif at 4 years (OR 0.21; 95% CI, 0.0-0.9, P=0.037) but this finding was partly explained by adjusting for RF (adjusted OR 0.24; 95% CI 0.04-1.37). In this study of recent onset IA, active disease and RF were associated with poor outcome. Whilst SE did not predict erosive disease, patients with DERAA motif may be protected against erosions whilst the presence of two SE alleles suggests persistence of arthritis.
AuthorsA Stockman, B D Tait, R Wolfe, C A Brand, M J Rowley, M D Varney, R Buchbinder, K D Muirden
JournalRheumatology international (Rheumatol Int) Vol. 26 Issue 6 Pg. 500-9 (Apr 2006) ISSN: 0172-8172 [Print] Germany
PMID16151812 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Epitopes
  • Genetic Markers
  • HLA-DR Antigens
  • Rheumatoid Factor
Topics
  • Age of Onset
  • Arthritis (diagnostic imaging, genetics, immunology, pathology, physiopathology, therapy)
  • Cohort Studies
  • Epitopes (blood)
  • Female
  • Follow-Up Studies
  • Foot (diagnostic imaging, pathology)
  • Genetic Markers
  • HLA-DR Antigens (blood, immunology)
  • Hand (diagnostic imaging, pathology)
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Radiography
  • Remission Induction
  • Rheumatoid Factor (blood)
  • Risk Factors
  • Severity of Illness Index
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: